Yat Sun Or, Chief Scientific Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 3,750 shares at $43.35 ($161K) on 2015-08-10, disclosed to the SEC on 2015-08-11.
Scheduled sale ($161k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.57 | 2,150 | $92K | 56.9% |
| 2 | $43.35 | 1,600 | $69K | 43.1% |
| Total | $42.90 avg | 3,750 | $161K | 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $23K | — | Filing → |
| ENTA | SELL | 2023-03-17 | $1.2M | — | Filing → |
| ENTA | SELL | 2019-03-04 | $2.1M | — | Filing → |